Erytech Pharma S.A. Stock
Your prediction
Erytech Pharma S.A. Stock
Our community identified positive and negative aspects for Erytech Pharma S.A. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Erytech Pharma S.A. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Erytech Pharma S.A. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Erytech Pharma S.A. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Erytech Pharma S.A. | - | - | - | - | - | - | - |
| Nanobiotix | 2.230% | 0.778% | 5.287% | 863.790% | 49.110% | 1593.222% | 118.573% |
| Innate Pharma | 0.680% | 4.401% | 12.098% | -36.645% | -22.484% | -56.397% | -66.573% |
| Poxel S.A. | -1.190% | -6.916% | 8.261% | -36.802% | 4.184% | -60.539% | -96.242% |
